Results 201 to 210 of about 8,221,589 (337)
Aggressive prostate cancer is associated with pericyte dysfunction
Molecular Oncology, EarlyView.Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Trends in MedEdPORTAL Faculty Development Resources for Clinician Educators. [PDF]
J Grad Med EducAnees A +3 more
europepmc +1 more source
Government publications: Asian Americans in federal and state government publications [PDF]
, 1977 Whitlatch, Jo Bell
core +1 more source
University of Texas Publications for 1959 [PDF]
, 1959 University of Texas at Austin
core +1 more source
Molecular Oncology, EarlyView.Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Knowledge mapping and visualization of immune checkpoint inhibitor-related pneumonitis: a bibliometric analysis. [PDF]
Discov OncolJiang Y, Xu M, Xu S, Wu Q.
europepmc +1 more source
Imperial strategy of cancer cells through mitochondrial transfer
Molecular Oncology, EarlyView.Cangkrama et al. demonstrated that cancer cells donate their mitochondria to fibroblasts through mitochondrial transfer, reprogramming them into ‘MitoCAF’. Likewise, our group has identified mitochondrial transfer from cancer cells to tumor infiltrating lymphocytes, resulting in mitochondrial ‘hijack’ and impaired antitumor immunity.
Takamasa Ishino, Yosuke Togashi
wiley +1 more source